Market Research Logo

Hemostasis - Medical Devices Pipeline Assessment, 2018

Hemostasis - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Hemostasis - Medical Devices Pipeline Assessment, 2018 provides an overview of Hemostasis currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hemostasis Overview
3 Products under Development
3.1 Hemostasis - Pipeline Products by Stage of Development
3.2 Hemostasis - Pipeline Products by Segment
3.3 Hemostasis - Pipeline Products by Territory
3.4 Hemostasis - Pipeline Products by Regulatory Path
3.5 Hemostasis - Pipeline Products by Estimated Approval Date
4 Hemostasis - Pipeline Products under Development by Companies
4.1 Hemostasis Companies - Pipeline Products by Stage of Development
4.2 Hemostasis - Pipeline Products by Stage of Development
5 Hemostasis Companies and Product Overview
5.1 Alere Inc Company Overview
5.2 Analyticon Biotechnologies AG Company Overview
5.3 Atomo Diagnostics Pty Limited Company Overview
5.4 BioMedica USA LLC (Inactive) Company Overview
5.5 Braun Biosystems, Inc. Company Overview
5.6 Carclo Diagnostic Solutions Ltd Company Overview
5.7 Cascade Metrix LLC Company Overview
5.8 Diagnostica Stago Inc Company Overview
5.9 Edan Instruments Inc Company Overview
5.10 EKF Diagnostics Holdings Plc Company Overview
5.11 ELITechGroup Inc Company Overview
5.12 Emosis SAS Company Overview
5.13 Gen-Probe Inc Company Overview
5.14 Grifols SA Company Overview
5.15 Grifols USA LLC Company Overview
5.16 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
5.17 Helena Laboratories Corp Company Overview
5.18 HemoSonics, LLC Company Overview
5.19 Instrumentation Laboratory Company Overview
5.20 Massachusetts General Hospital Company Overview
5.21 Nexus Medical, LLC Company Overview
5.22 Novametics Inc (Inactive) Company Overview
5.23 Pakwa Technologies Company Overview
5.24 PortaScience Inc Company Overview
5.25 Precision Biologics Inc Company Overview
5.26 Radiometer Medical ApS Company Overview
5.27 Rappaport Family Institute for Research in the Medical Science Company Overview
5.28 rHealth Company Overview
5.29 SATT Conectus Alsace SAS Company Overview
5.30 Sekisui Diagnostics LLC Company Overview
5.31 Siemens Healthcare GmbH Company Overview
5.32 SonoMedix, Inc. Company Overview
5.33 SQI Diagnostics Inc Company Overview
5.34 Stichting Lygature Company Overview
5.35 Tarabios Company Overview
5.36 Transfusion & Transplantation Technologies (Inactive) Company Overview
5.37 Universal Biosensors Inc Company Overview
5.38 University of Colorado Company Overview
5.39 University of Michigan Company Overview
5.40 University of Texas Health Science Center at Houston Company Overview
5.41 University of Vermont Company Overview
6 Hemostasis- Recent Developments
6.1 Jun 28, 2018: Baxter Releases 2017 Corporate Responsibility Report and Reinforces Its Commitment to Enriching Communities Around the World
6.2 Jun 18, 2018: IBEX Announces Financial Results for the Third Quarter and the Nine Months Ended April 30, 2018
6.3 Jun 18, 2018: Abcam Appoints Peter Allen As Chairman
6.4 Jun 14, 2018: EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization
6.5 Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director
6.6 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers
6.7 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.8 May 25, 2018: Groundbreaking POC hemostasis diagnostic to be presented at Major European Meetings
6.9 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends
6.10 May 25, 2018: Siemens appoints new CEO of Siemens Mexico, Central America, and Caribbean
6.11 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.12 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency
6.13 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
6.14 May 15, 2018: Proposed nominations of future Siemens Alstom Board of Directors completed
6.15 May 10, 2018: SQI Diagnostics Reports Second Quarter 2018 Results
6.16 May 09, 2018: Siemens Announces Earnings Release and Financial Results Q2 FY 2018
6.17 May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals
6.18 May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018
6.19 May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results
6.20 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.21 May 07, 2018: Instrumentation Laboratory Worldwide Sales Top $970 M In 2017
6.22 May 03, 2018: Siemens Healthineers fully on track to meet the targets
6.23 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales
6.24 May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018
6.25 May 01, 2018: Trinity Biotech announces Results for Q1, 2018
6.26 May 01, 2018: Predicting side effects before they happen
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Hemostasis - Pipeline Products by Stage of Development
Table 2: Hemostasis - Pipeline Products by Segment
Table 3: Hemostasis - Pipeline Products by Territory
Table 4: Hemostasis - Pipeline Products by Regulatory Path
Table 5: Hemostasis - Pipeline Products by Estimated Approval Date
Table 6: Hemostasis Companies - Pipeline Products by Stage of Development
Table 7: Hemostasis - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Afinion PT Test - Capillary Blood - Product Status
Table 10: Afinion PT Test - Capillary Blood - Product Description
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Coagulyzer 1 - Product Status
Table 13: Coagulyzer 1 - Product Description
Table 14: Coagulyzer 100 - Product Status
Table 15: Coagulyzer 100 - Product Description
Table 16: Coagulyzer 2 - Product Status
Table 17: Coagulyzer 2 - Product Description
Table 18: Coagulyzer 4 - Product Status
Table 19: Coagulyzer 4 - Product Description
Table 20: Fibrinogen Lyophilisat Coagulation Kit - Product Status
Table 21: Fibrinogen Lyophilisat Coagulation Kit - Product Description
Table 22: Prothrombin Time Coagulation Reagent - Product Status
Table 23: Prothrombin Time Coagulation Reagent - Product Description
Table 24: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 25: AtomoRapid - Coagulation Monitoring - Product Status
Table 26: AtomoRapid - Coagulation Monitoring - Product Description
Table 27: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Portable Diagnostic System - Hemostasis - Product Status
Table 29: Portable Diagnostic System - Hemostasis - Product Description
Table 30: Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Bio6 - Product Status
Table 32: Bio6 - Product Description
Table 33: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Micropoc-CAT - Haemostasis Assay - Product Status
Table 35: Micropoc-CAT - Haemostasis Assay - Product Description
Table 36: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Multiple Blood Analytes Test - Product Status
Table 38: Multiple Blood Analytes Test - Product Description
Table 39: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Calibrated Automated Thrombogram - Thrombin Assay - Product Status
Table 41: Calibrated Automated Thrombogram - Thrombin Assay - Product Description
Table 42: STA Compact Max - NeoPTimal ISI - Product Status
Table 43: STA Compact Max - NeoPTimal ISI - Product Description
Table 44: STA Compact Max - Ristocetin Cofactor Assay - Product Status
Table 45: STA Compact Max - Ristocetin Cofactor Assay - Product Description
Table 46: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status
Table 47: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description
Table 48: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status
Table 49: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description
Table 50: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status
Table 51: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description
Table 52: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
Table 53: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
Table 54: STA-R Max - NeoPTimal ISI - Product Status
Table 55: STA-R Max - NeoPTimal ISI - Product Description
Table 56: STA-R Max - Ristocetin Cofactor Assay - Product Status
Table 57: STA-R Max - Ristocetin Cofactor Assay - Product Description
Table 58: STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status
Table 59: STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description
Table 60: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: i15 - Coagulation Test - Product Status
Table 62: i15 - Coagulation Test - Product Description
Table 63: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Point-Of-Care Test - Coagulation - Product Status
Table 65: Point-Of-Care Test - Coagulation - Product Description
Table 66: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: ELITe InGenius - Coagulation Factors Panel - Product Status
Table 68: ELITe InGenius - Coagulation Factors Panel - Product Description
Table 69: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 70: ClotSeek - Product Status
Table 71: ClotSeek - Product Description
Table 72: Gen-Probe Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Diagnostic Assay - Coagulation Disorders - Product Status
Table 74: Diagnostic Assay - Coagulation Disorders - Product Description
Table 75: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 76: DG-Chrom PC - Product Status
Table 77: DG-Chrom PC - Product Description
Table 78: Hemostasis Reagent - DG-APC - Product Status
Table 79: Hemostasis Reagent - DG-APC - Product Description
Table 80: Hemostasis Reagent - DG-Chrom Hep - Product Status
Table 81: Hemostasis Reagent - DG-Chrom Hep - Product Description
Table 82: Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human - Product Status
Table 83: Hemostasis Reagent Kit - DG-APTT Synth G-Fib L Human - Product Description
Table 84: Hemostasis Reagent Kit - DG-FII - Product Status
Table 85: Hemostasis Reagent Kit - DG-FII - Product Description
Table 86: Hemostasis Reagent Kit - DG-FIX - Product Status
Table 87: Hemostasis Reagent Kit - DG-FIX - Product Description
Table 88: Hemostasis Reagent Kit - DG-FV - Product Status
Table 89: Hemostasis Reagent Kit - DG-FV - Product Description
Table 90: Hemostasis Reagent Kit - DG-FVII - Product Status
Table 91: Hemostasis Reagent Kit - DG-FVII - Product Description
Table 92: Hemostasis Reagent Kit - DG-FVIII - Product Status
Table 93: Hemostasis Reagent Kit - DG-FVIII - Product Description
Table 94: Hemostasis Reagent Kit - DG-FX - Product Status
Table 95: Hemostasis Reagent Kit - DG-FX - Product Description
Table 96: Hemostasis Reagent Kit - DG-FXI - Product Status
Table 97: Hemostasis Reagent Kit - DG-FXI - Product Description
Table 98: Hemostasis Reagent Kit - DG-FXII - Product Status
Table 99: Hemostasis Reagent Kit - DG-FXII - Product Description
Table 100: Hemostasis Reagent Kit - DG-Latex D Dimer - Product Status
Table 101: Hemostasis Reagent Kit - DG-Latex D Dimer - Product Description
Table 102: Hemostasis Reagent Kit - DG-Latex VWF: Gp1b - Product Status
Table 103: Hemostasis Reagent Kit - DG-Latex VWF: Gp1b - Product Description
Table 104: Hemostasis Reagent Kit - DG-PT RecombiLIQ - Product Status
Table 105: Hemostasis Reagent Kit - DG-PT RecombiLIQ - Product Description
Table 106: Hemostasis Reagent Kit - DG-TT L Human - Product Status
Table 107: Hemostasis Reagent Kit - DG-TT L Human - Product Description
1.2 List of Figures
Figure 1: Hemostasis - Pipeline Products by Stage of Development
Figure 2: Hemostasis - Pipeline Products by Segment
Figure 3: Hemostasis - Pipeline Products by Territory
Figure 4: Hemostasis - Pipeline Products by Regulatory Path
Figure 5: Hemostasis - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report